Medical Companies

Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
About Vandalia Research – Vandalia Research, Inc. is a life sciences research company based in West Virginia, and was formed as a direct result of the above E-team research. Vandalia has placed strong emphasis on research and development directed to specific market needs, with the objective of commercializing novel biotechnology instrumentation and advanced biotechnology manufacturing techniques. Vandalia is developing tools, such as Triathlon, to be competitive in a large marketplace. Vandalia will use these tools to market DNA products and services to commercial, educational, and other research facilities. In addition, Vandalia is seeking strategic partnerships to broaden the use of novel instrumentation and manufacturing techniques. ( www.vandaliaresearch.com )

Vandalia Research , Inc.
940 Fourth Avenue Suite 350
Huntington, West Virginia 25701
USA

Tel: (304) 529-0803
Fax: (888) 550-8220

Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Cytokine PharmaSciences (“CPSI”) is the result of the June 1999 merger of PharmaSciences, Inc. (“PSI”) into Cytokine Networks, Inc. (“CNI”). CNI was formed in 1993 to further discoveries made at a nonprofit charitable trust called The Picower Institute for Medical Research (“PIMR”). PSI was founded in 1992 and, in May 1993, acquired Controlled Therapeutics (Scotland) Limited (“CTS”). CTS, formed in 1986, developed the Cervidil® vaginal insert (Propess® in certain countries) based upon its proprietary polymer drug delivery technology. CPSI currently operates out of its headquarters in King of Prussia (near Philadelphia), Pennsylvania. CTS is located in East Kilbride (near Glasgow), ( www.cytokinepharmasciences.com )

Cytokine PharmaSciences , Inc.
150 South Warner Road Suite 420
King Of Prussia, Pennsylvania 19406
USA

Tel: (610) 687-1776
Fax: (610) 687-4340

Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Sequoia Pharmaceuticals discovers and develops revolutionary new treatments for viral diseases including HIV/AIDS and HCV-induced hepatitis with a focus on the growing global problem of drug-resistant infectious diseases. Most anti-infective drugs were designed to block the most prevalent form of a pathogen. Those drugs are doomed to become obsolete due to the emergence of drug-resistant mutations. Sequoia’s mission includes meeting this challenging problem by developing effective therapeutic solutions to combat the emergence of drug ( www.sequoiapharma.com )

Sequoia Pharmaceuticals , Inc.
401 Professional Drive Suite 200
Gaithersburg, Maryland 20879
USA

Tel: (240) 632-0094
Fax: (240) 632-0465

Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
NeuroHealing Pharmaceuticals Inc. (www.NeuroHealing.com) is a clinical stage company developing therapies to improve the neuro-rehabilitation process and functional outcome for patients who have suffered debilitating injuries to the central nervous system. Clinical stage programs include NH001 (phase II) a dopaminergic agent to help post traumatic brain injury patients to emerge from a coma, vegetative or minimally consciousness state NH004 (phase II) an anticholinergic agent in a convenient intra- orally muco-adhesive dissolving film to help treat motor neuron patients who suffer from sialorrhea (drooling) and NH02D a novel mechanism compound to accelerate the rehabilitation outcomes of stroke patients who remain with chronic motor and cognitive disabilities. ( www.neurohealing.com )

NeuroHealing Pharmaceuticals , Inc.
50 Undine Road, Unit #1
Newton, Massachusetts 02135
USA

Tel: (617) 331-4111

Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Light Sciences Corporation, founded in 1995, is a privately owned company developing Light Infusion TechnologyÔ ( Litxcombination product containing a drug activated by red light. The drug activation is accomplished via a proprietary light infusion device powered by tiny light emitting diodes (LEDs), directed or placed in a minimally invasive procedure inside a disease target for the purpose of precise localized tissue effects. Light Infusion Technology represents an important step forward in the clinical application of light activated drugs in oncology, cardiovascular and ophthalmologic diseases. The company has built a strong pipeline of investigational light activated drugs by licensing promising compounds, including those with previous clinical experience. ( www.lightsciences.com )

Light Sciences Corporation
34931 SE Douglas Street Suite 200
Snoqualmie, Washington 98065
USA

Tel: (425) 369-2800
Fax: (425) 369-2801

Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
PhageGenÔ has established a strong technology base in infectious disease microbiology, bacteriophage biology and viral molecular genetics. The Company has established business and laboratory operations in the United Kingdom, France and the US to focus its resources on targeted business and strategic planning, as well as the implementation of an R&D program that will result in the commercial introduction of products for the treatment of selected bacterial infectious diseases, initially TB, MDRTB, Staphylococcus, Anthrax, Pseudomonas and others. PhageGenÔ considers intellectual property as fundamental to its long-term success, and has adopted a program to identify and protect intellectual property and to characterize, develop and patent novel technologies created within its laboratories. ( www.phagegen.com )

PHAGE GENOMICS, INC
2215 Lucerne Circle
Henderson, Nevada 89104
USA

Tel: (702) 451-4981

Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
VGX Pharmaceuticals is a leading biopharmaceutical company with strong product candidates for the treatment of infectious diseases including HIV and hepatitis C virus (HCV) as well as cancer and inflammatory diseases. The Company’s clinical development programs include PICTOVIRÔ for HIV infection and VGX-410C for chronic HCV infection, which are currently in Phase II clinical trials. In addition, a Phase I clinical trial will be initiated in 2007 for the Company’s lead cancer drug compound, VGX-150 for the treatment of Melanoma. Moreover, VGX Pharmaceuticals’ therapeutic platform is designed to advance a strong and continual pipeline of additional drug candidates into the clinic with VGX-100 for cancer therapy and VGX-1027 and VGX-750 for inflammatory diseases currently in development. ( www.vgxp.com )

VGX Pharmaceuticals
450 Sentry Parkway
Blue Bell, Pennsylvania 19422
USA

Tel: (267) 440-4200

Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
AustarPharma, LLC is a US based pharmaceutical company located in the world pharmaceutical capital¡ªNew Jersey, where headquartered more than 70% major multinational pharmaceutical companies with their R&D center. AustarPharma is a rapidly growing pharmaceutical company engaged in pharmaceutical research and development (R&D), commercial manufacturing and marketing of pharmaceutical finished products and related healthcare products for the worldwide markets. Austarpharma primarily focuses on drug delivery technology research, new drug development as well as generic drug development for the US market. ( www.austarpharma.com )

AustarPharma LLC
300 Columbus Circle Unit F
Edison, New Jersey 08837
USA

Tel: (732) 225-8850
Fax: (732) 225-8828

Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Lifelike Biomatic develops new drugs that act on a combination of multiple known targets of disease mechanisms, and could lead to new therapies for cognitive disorders such as Alzheimer’s disease. Our scientists have shown that drugs which act on multiple targets have higher efficacy at lower doses, resulting in an improved safety-efficacy profile. Our discovery approach is driven by a patented simulation-based platform that integrates the complex network of targets of disease mechanisms and identifies optimal patterns of synergistic physiological activities. ( www.lifelikebiomatic.com )

Lifelike Biomatic Inc
2501 Wildwood Way
Roanoke, Texas 75262
USA

Tel: (817) 253-4129